{"id":3644,"date":"2023-02-27T15:19:01","date_gmt":"2023-02-27T14:19:01","guid":{"rendered":"https:\/\/www.access2meds.eu\/pocetna-stranica\/"},"modified":"2025-06-24T11:02:48","modified_gmt":"2025-06-24T09:02:48","slug":"pocetna-stranica","status":"publish","type":"page","link":"https:\/\/www.access2meds.eu\/hr\/","title":{"rendered":"Naslovna stranica"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”Header” _builder_version=”4.20.2″ _module_preset=”default” background_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg” background_position=”top_center” height=”100vh” max_height=”660px” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.0″ _module_preset=”default” custom_padding=”7px|30px||30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” header_font=”|700|||||||” header_line_height=”1.1em” custom_margin=”11px||||false|false” global_colors_info=”{}”]<\/p>\n

POBOLJ\u0160ANJE DOSTUPNOSTI<\/span>
INOVATIVNIM ZDRAVSTVENIM TEHNOLOGIJAMA<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”first text blue pill” _builder_version=”4.20.0″ _module_preset=”default” background_enable_color=”off” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_row custom_padding_last_edited=”on|phone” module_class=”starttoppill” _builder_version=”4.20.2″ _module_preset=”default” background_color=”#3b3e84″ vertical_offset=”-90px” max_width=”1500px” module_alignment=”right” custom_margin=”||||false|false” custom_padding=”60px||50px|93px|false|false” custom_padding_tablet=”60px||50px|93px|false|false” custom_padding_phone=”|10px||65px|false|false” custom_css_main_element=”width:calc(100% – 125px)!important;” border_radii=”off|99999px|||99999px” global_colors_info=”{}” custom_css_main_element_last_edited=”on|phone” custom_css_main_element_phone=”width:calc(100%)!important;” custom_css_main_element_tablet=”width:calc(100% – 125px)!important;”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_font=”||||||||” text_text_color=”#FFFFFF” text_font_size=”24px” text_line_height=”1.33em” width=”100%” max_width=”825px” custom_margin_tablet=”” custom_margin_phone=”||0px||false|false” custom_margin_last_edited=”on|phone” custom_padding_tablet=”” custom_padding_phone=”||0px|10px|false|false” custom_padding_last_edited=”on|phone” text_font_size_tablet=”22px” text_font_size_phone=”16px” text_font_size_last_edited=”on|phone” text_line_height_tablet=”1.33em” text_line_height_phone=”1.2em” text_line_height_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n

ASCERTAIN (Affordability and Sustainability improvements through new pricing, Cost- Effectiveness and ReimbursemenT models to Appraise INnovative health technologies) bavi se potrebom pacijenata, lije\u010dnika, platitelja, regulatora i proizvo\u0111a\u010da za pobolj\u0161anje priu\u0161tivosti i dostupnosti inovativniim zdravstvenim tehnologijama (uklju\u010duju\u0107i lijekove) u Europi.<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/www.access2meds.eu\/hr\/utjecaj\/” button_text=”Saznajte kako mo\u017eete imati koristi!” button_alignment=”right” module_class=”bubble-button” _builder_version=”4.20.2″ _module_preset=”default” custom_button=”on” button_text_size=”24px” button_text_color=”#FFFFFF” button_bg_color=”RGBA(255,255,255,0)” button_border_width=”0px” button_font=”||||||||” button_icon=”9||divi||400″ button_on_hover=”off” button_text_size_tablet=”24px” button_text_size_phone=”16px” button_text_size_last_edited=”on|phone” custom_css_main_element=”font-weight:500;” custom_css_after=”border-radius: 50%;background: #e85d6b;|| width: 30px;|| height: 30px;|| text-align: center; top:10px;|| line-height: 30px !important;” global_colors_info=”{}” custom_css_after_last_edited=”on|phone” custom_css_after_phone=”border-radius: 50%;background: #e85d6b;|| width: 20px;|| height: 20px;|| text-align: center; top:8px;|| line-height: 20px !important;” custom_css_after_tablet=”border-radius: 50%;background: #e85d6b;|| width: 30px;|| height: 30px;|| text-align: center; top:10px;|| line-height: 30px !important;”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”faq” module_id=”utvrditi-\u010desta pitanja” _builder_version=”4.20.2″ _module_preset=”default” overflow-x=”hidden” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.0″ _module_preset=”default” custom_padding=”0px|30px||30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_font=”|600|||||||” text_font_size=”36px” header_font=”|600|||||||” header_text_align=”left” header_text_color=”#FFFFFF” header_font_size=”36px” header_line_height=”75px” background_color=”#e85d6b” background_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg” background_size=”custom” background_image_width=”31px” background_image_height=”30px” background_position=”center_right” background_horizontal_offset=”27px” width=”160px” height=”75px” height_tablet=”75px” height_phone=”50px” height_last_edited=”on|phone” custom_padding=”|86px|||false|false” link_option_url=”https:\/\/www.access2meds.eu\/faq\/” header_font_size_tablet=”36px” header_font_size_phone=”24px” header_line_height_tablet=”75px” header_line_height_phone=”50px” header_line_height_last_edited=”on|phone” custom_css_main_element=”overflow:visible;” custom_css_after=”content:%22%22; display:block; width:2000px; height:100%; background:#e85d6b; position:absolute; top:0;right:160px;” border_radii=”off||9999px|9999px|” global_colors_info=”{}”]<\/p>\n

FAQ<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.0″ _module_preset=”default” background_color=”#fbedec” positioning=”absolute” position_origin_a=”top_center” vertical_offset=”408px” max_width=”100%” height=”675px” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.20.0″ _module_preset=”default” custom_padding=”|30px|60px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”\u0160to je ASCERTAIN?” image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-542576580_sturti-1024×683.jpg” image_icon_width=”100%” _builder_version=”4.20.2″ _module_preset=”4d864e31-c790-4706-8bfe-634bfca688dd” global_colors_info=”{}”]<\/p>\n

ASCERTAIN je projekt usmjeren na pomo\u0107 ljudima kako bi imali bolju dostupnost novim zdravstvenim tehnologijama kao \u0161to su lijekovi, medicinski ure\u0111aji i testovi. Projekt stvara alat koji donositelji odluka mogu koristiti za razumijevanje tro\u0161kova i vrijednosti tih novih zdravstvenih tehnologija. <\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”\u0160to je \u201cASCERTAIN alat za podr\u0161ku politikama\u201d?” image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1349268982-1024×683.jpg” image_icon_width=”100%” _builder_version=”4.20.2″ _module_preset=”4d864e31-c790-4706-8bfe-634bfca688dd” background_color=”#393C84″ custom_margin_tablet=”||0px||false|false” custom_margin_phone=”||0px||false|false” custom_margin_last_edited=”on|tablet” global_colors_info=”{}”]<\/p>\n

Alat \u0107e biti dostupan svima na internetu i sadr\u017eavat \u0107e informacije o cijeni i vrijednosti novih zdravstvenih tehnologija. Tako\u0111er \u0107e uzeti u obzir utjecaj na okoli\u0161. Projekt \u0107e sura\u0111ivati s pacijentima, industrijom, kreatorima politika i platiteljima kako bi se osigurala kvaliteta i koristan alat. <\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}” custom_css_main_element_last_edited=”on|tablet” custom_css_main_element_tablet=”margin-bottom:0 !important;” custom_css_main_element_phone=”margin-bottom:0 !important;”][et_pb_blurb title=”Za\u0161to je priu\u0161tivost inovativnih zdravstvenih tehnologija izazov?” image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1440000552-1024×683.jpg” _builder_version=”4.20.2″ _module_preset=”4d864e31-c790-4706-8bfe-634bfca688dd” background_color=”#E85D6B” custom_margin=”60px||30px||false|false” custom_margin_tablet=”0px||30px||false|false” custom_margin_phone=”0px||30px||false|false” custom_margin_last_edited=”on|tablet” global_colors_info=”{}”]<\/p>\n

Za mnoge zemlje Europske unije izazov je priu\u0161titi si nove zdravstvene tehnologije jer su \u010desto skupe i nemaju im svi jednak pristup. Ovaj alat pomo\u0107i \u0107e donositeljima odluka da spoznaju koliko bi tehnologija trebala ko\u0161tati, dodanu vrijednost koju pru\u017ea pacijentima i njezin potencijalni utjecaj na prora\u010dun za zdravstvo. <\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”Koji su ciljevi ASCERTAIN-a?” image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Foto_1132274611_iStock_PeopleImages-1024×653.jpg” _builder_version=”4.20.2″ _module_preset=”4d864e31-c790-4706-8bfe-634bfca688dd” background_color=”#86B8BD” custom_margin=”||||false|false” global_colors_info=”{}”]<\/p>\n

Cilj ASCERTAIN-a je olak\u0161ati ljudima razumijevanje tro\u0161kova i vrijednosti novih zdravstvenih tehnologija. Alat \u0107e biti dostupan svima i mo\u0107i \u0107e se prilagoditi potrebama razli\u010ditih zemalja. Sadr\u017eavat \u0107e informacije o tro\u0161kovima i vrijednosti navedenih tehnologija te \u0107e poticati \u201ezeleniju\u201c proizvodnju. <\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ disabled_on=”on|on|off” module_id=”jezik” _builder_version=”4.27.4″ _module_preset=”default” background_color=”rgba(134,184,189,0.3)” background_enable_image=”off” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

BISTE LI VI\u0160E \u017dELILI \u010cITATI OVU STRANICU NA DRUGOM JEZIKU?<\/h3>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Englisch-1.png” title_text=”Sprechblase_Englisch” url=”https:\/\/www.access2meds.eu\/hr\/” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/06\/Sprechblase_Nederlands.png” title_text=”Sprechblase_Nederlands” url=”https:\/\/www.access2meds.eu\/nl\/” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Deutsch.png” title_text=”Sprechblase_Deutsch” url=”https:\/\/www.access2meds.eu\/de\/” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_France.png” title_text=”Sprechblase_Francuska” url=”https:\/\/www.access2meds.eu\/fr\/” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Romana.png” title_text=”Sprechblase_Romana” url=”https:\/\/www.access2meds.eu\/ro\/” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/06\/Sprechblase_Espanol.png” title_text=”Sprechblase_Espanol” url=”https:\/\/www.access2meds.eu\/es\/” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Norsk.png” title_text=”Sprechblase_Norsk” url=”https:\/\/www.access2meds.eu\/no\/” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Hrvatski.png” title_text=”Sprechblase_Hrvatski” url=”https:\/\/www.access2meds.eu\/hr\/” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”events” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.0″ _module_preset=”default” custom_padding=”14px|30px|4px|30px|false|true” locked=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.25.1″ _module_preset=”default” text_font=”|600|||||||” text_font_size=”36px” header_font=”|600||on|||||” header_text_align=”left” header_text_color=”#FFFFFF” header_font_size=”36px” header_line_height=”75px” background_color=”#393C84″ background_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg” background_size=”custom” background_image_width=”31px” background_image_height=”30px” background_position=”center_right” background_horizontal_offset=”27px” width=”222px” height=”75px” height_tablet=”75px” height_phone=”50px” height_last_edited=”on|phone” custom_padding=”|60px|||false|false” link_option_url=”https:\/\/www.access2meds.eu\/hr\/vijesti-i-dogadaji\/#ascertain-events” header_font_size_tablet=”36px” header_font_size_phone=”24px” header_line_height_tablet=”75px” header_line_height_phone=”50px” header_line_height_last_edited=”on|phone” custom_css_main_element=”overflow:visible;” custom_css_after=”content:%22%22; display:block; width:2000px; height:100%; background:#393c84; position:absolute; top:0;right:222px;” border_radii=”off||9999px|9999px|” global_colors_info=”{}”]<\/p>\n

Events<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.0″ _module_preset=”default” max_width=”1170px” custom_padding=”0px|0px||0px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_code _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”]

\r\n\t
\r\n\t
\r\n\t
\r\n\t\t\t
\r\n\t\t\t\t21
-
21<\/span>\r\n\t\t\t\tlis<\/span>\r\n\t\t\t<\/div>\r\n\t<\/div>\r\n\t\r\n\t
\r\n\t\t
\r\n\t\t\t\r\n\t\t\r\n\t\t

ASCERTAIN Final Conference<\/a><\/h3>\r\n\r\n\t\t
\r\n\t\t\t

Join us in Brussels for our final ASCERTAIN conference.<\/p>\n\r\n\t\t\t\r\n\t\t<\/div>\r\n\t\t<\/div>\r\n\t\t

\r\n\t\t\t<\/a>\r\n\t\t\t\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\t<\/div>\r\n<\/div>[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”partnerlogos” module_id=”utvrditi-vijesti” _builder_version=”4.20.2″ _module_preset=”default” background_color=”#FFFFFF” custom_padding=”0px||0px||true|false” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.0″ _module_preset=”default” positioning=”absolute” position_origin_a=”top_center” custom_padding=”0px|30px|0px|30px|true|true” locked=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.24.2″ _module_preset=”default” text_font=”|600|||||||” text_font_size=”36px” header_font=”|600|||||||” header_text_align=”left” header_text_color=”#FFFFFF” header_font_size=”36px” header_line_height=”75px” background_color=”#86B8BD” background_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg” background_size=”custom” background_image_width=”31px” background_image_height=”30px” background_position=”center_right” background_horizontal_offset=”27px” width=”340px” width_tablet=”340px” width_phone=”250px” width_last_edited=”on|phone” height=”75px” height_tablet=”75px” height_phone=”50px” height_last_edited=”on|phone” custom_padding=”|86px|||false|false” link_option_url=”https:\/\/www.access2meds.eu\/hr\/konzorcij\/” header_font_size_tablet=”36px” header_font_size_phone=”24px” header_line_height_tablet=”75px” header_line_height_phone=”50px” header_line_height_last_edited=”on|phone” custom_css_main_element=”overflow:visible;” custom_css_after=”content:%22%22; display:block; width:2000px; height:100%; background:#048ea3; position:absolute; top:0;right:100%;” border_radii=”off||9999px|9999px|” global_colors_info=”{}”]<\/p>\n

VIDEO<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”news” module_id=”utvrditi-vijesti” _builder_version=”4.20.2″ _module_preset=”default” background_color=”#E85D6B” custom_padding=”0px||0px||true|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.2″ _module_preset=”default” positioning=”absolute” position_origin_a=”top_center” z_index=”100″ custom_padding=”0px|30px|0px|30px|true|true” locked=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_font=”|600|||||||” text_font_size=”36px” header_font=”|600||on|||||” header_text_align=”left” header_text_color=”#FFFFFF” header_font_size=”36px” header_line_height=”75px” background_color=”#048EA3″ background_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg” background_size=”custom” background_image_width=”31px” background_image_height=”30px” background_position=”center_right” background_horizontal_offset=”27px” width=”190px” height=”75px” height_tablet=”75px” height_phone=”50px” height_last_edited=”on|phone” custom_padding=”|60px|||false|false” link_option_url=”https:\/\/www.access2meds.eu\/hr\/vijesti-i-dogadaji\/” header_font_size_tablet=”36px” header_font_size_phone=”24px” header_line_height_tablet=”75px” header_line_height_phone=”50px” header_line_height_last_edited=”on|phone” custom_css_main_element=”overflow:visible;” custom_css_after=”content:%22%22; display:block; width:2000px; height:100%; background:#048ea3; position:absolute; top:0;right:100%;” border_radii=”off||9999px|9999px|” global_colors_info=”{}”]<\/p>\n

News<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.0″ _module_preset=”default” max_width=”100%” module_alignment=”center” custom_padding=”0px|0px|0px||true|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_dp_dmb_module_205 _builder_version=”4.20.0″ _module_preset=”default” custom_padding=”|||30px|false|false” global_colors_info=”{}”][\/et_pb_dp_dmb_module_205][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” background_enable_color=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” header_2_font=”|600||on|||||” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” locked=”off” global_colors_info=”{}”]<\/p>\n

Pogledajte na\u0161e videozapise kako biste saznali vi\u0161e o projektu<\/h2>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/www.youtube.com\/watch?v=JjYDG7BDNDE” _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

Otkrijte kako je nastala serija od \u0161est dijelova \u20183 stvari o\u2019. U \u0161est videa nastojimo slo\u017eena pitanja u\u010diniti dostupnijima, poti\u010du\u0107i dublje razumijevanje izazova i prilika u temama vezanim uz ASCERTAIN. <\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/www.youtube.com\/watch?v=6ZtwscRvEls” _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

\u201c\u201c3 stvari o vrijednosti novih lijekova protiv raka\u201d \u2013 \u0160esti video u na\u0161oj seriji! Ovaj video istra\u017euje kako razli\u010diti dionici definiraju vrijednost novih lijekova protiv raka. <\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/youtu.be\/xMF2ddO9abM” _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

\u201c3 stvari o tro\u0161kovnoj u\u010dinkovitosti\u201d \u2013 Peti video u na\u0161oj seriji! Ovaj video istra\u017euje analizu tro\u0161ka i u\u010dinkovitosti \u2013 klju\u010dnu metodu za procjenu pru\u017eaju li intervencije dobru vrijednost. <\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/youtu.be\/e36OtJA90Qg” _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

“\u201c3 stvari o nadoknadi tro\u0161kova\u201d je \u010detvrti video u na\u0161oj seriji. U ovom videu istra\u017eujemo slo\u017eenost nadoknade tro\u0161kova lijekova \u2013 klju\u010dnog \u010dimbenika u osiguravanju dostupnosti novim lijekovima. <\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/www.youtube.com\/watch?v=6ZtwscRvEls” _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

\u201c3 stvari o odre\u0111ivanju cijena novih lijekova\u201d \u2013 Tre\u0107i video u na\u0161oj seriji! U ovom videu istra\u017eujemo \u010dimbenike koji utje\u010du na odre\u0111ivanje cijena lijekova \u2013 klju\u010dnu temu u priu\u0161tivosti zdravstvene skrbi. <\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/www.youtube.com\/watch?v=OlmiWOpy6IA&t=2s” _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

\u201c3 stvari o slojevitom odre\u0111ivanju cijena\u201d \u2013 Drugi video u na\u0161oj seriji! U ovom videu obja\u0161njavamo koncept slojevitog odre\u0111ivanja cijena \u2013 strategiju koja se koristi za odre\u0111ivanje razli\u010ditih cijena lijekova u razli\u010ditim zemljama i skupinama pacijenata. <\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/youtu.be\/8NhuaohK_Qg” _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.24.2″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

\u201c3 stvari o pristupu tr\u017ei\u0161tu\u201d \u2013 Prvi video u na\u0161oj seriji! U ovom videu istra\u017eujemo klju\u010dni koncept pristupa tr\u017ei\u0161tu \u2013 vitalni proces za dostupnost novih lijekova i intervencija pacijentima. <\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/www.youtube.com\/watch?v=fvjJ4-2nOxk” _builder_version=”4.24.2″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.24.2″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

Webinar \u201cOsnove odre\u0111ivanja cijena lijekova u Europi\u201d odr\u017ean je 07.03.2024., a vodila ga je Sabine Vogler, direktorica Suradni\u010dkog centra WHO-a za politiku odre\u0111ivanja cijena i naknada tro\u0161kova lijekova i voditeljica Odjela za farmakoekonomiju Austrijskog nacionalnog instituta za javno zdravstvo. <\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/youtu.be\/sbPnTmX8Uxs” _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

Sretni smo \u0161to mo\u017eemo podijeliti na\u0161 video koji prikazuje po\u010detak projekta ASCERTAIN u Rotterdamu! \u010clanovi na\u0161eg konzorcija okupili su se kako bi zapo\u010deli ovaj HORIZON projekt financiran sa strane EU. <\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ module_id=”kontakt” _builder_version=”4.20.2″ _module_preset=”default” background_color=”#86B8BD” custom_margin=”||||false|false” custom_padding=”16px||75px||false|false” box_shadow_style=”preset7″ box_shadow_horizontal=”0px” box_shadow_vertical=”-274px” box_shadow_color=”#FFFFFF” global_module=”910″ saved_tabs=”all” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” header_font=”Poppins semibold|||on|||||” header_font_size=”36px” custom_margin=”14px||23px||false|false” custom_margin_tablet=”” custom_margin_phone=”||30px||false|false” custom_margin_last_edited=”on|phone” header_font_size_phone=”24px” global_colors_info=”{}”]<\/p>\n

Kontakt<\/h1>\n

[\/et_pb_text][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_font=”Poppins regular||||||||” text_text_color=”#393C84″ text_font_size=”24px” text_line_height=”1.33em” module_alignment=”right” custom_margin=”||0px||false|false” text_font_size_tablet=”” text_font_size_phone=”18px” text_font_size_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n

Molimo kontaktirajte nas ako imate bilo kakvih pitanja ili komentara! Odgovorit \u0107emo vam u najkra\u0107em mogu\u0107em roku. <\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ use_custom_gutter=”on” module_class=”tablet-three-cols” _builder_version=”4.20.2″ _module_preset=”default” max_width_tablet=”980px” max_width_phone=”500px” max_width_last_edited=”on|phone” custom_padding=”0px|30px|0px|30px|false|true” global_colors_info=”{}” custom_css_main_element_last_edited=”on|phone” custom_css_main_element_tablet=”display:flex;” custom_css_main_element_phone=”display:flex; flex-direction:column;”][et_pb_column type=”1_3″ _builder_version=”4.20.2″ _module_preset=”be0fba28-f74a-4ba0-9a8d-9cd30aca805d” global_colors_info=”{}” custom_css_main_element_last_edited=”on|tablet” custom_css_main_element_tablet=”margin-bottom:0;” custom_css_main_element_phone=”margin-bottom:20px;”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Carin_Uyl-de-Groot.png” title_text=”Carin_Uyl-de-Groot” _builder_version=”4.20.2″ _module_preset=”a348f9e0-d57b-4c22-b522-c52b784fe57f” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_text_color=”#FFFFFF” link_text_color=”#FFFFFF” global_colors_info=”{}”]<\/p>\n

Za pitanja vezana uz istra\u017eivanje:<\/p>\n

Carin Uyl-de Groot<\/strong>
Koordinator projekta<\/p>\n

Sveu\u010dili\u0161te Erasmus u Rotterdamu
uyl@eshpm.eur.nl<\/a>
Telefon: +31 10 4081583<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.20.2″ _module_preset=”be0fba28-f74a-4ba0-9a8d-9cd30aca805d” background_color=”#393C84″ global_colors_info=”{}” custom_css_main_element_last_edited=”on|phone” custom_css_main_element_tablet=”margin-bottom:0;” custom_css_main_element_phone=”margin-bottom:20px;”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Marcel-Langone-1.png” title_text=”Marcel-Langone” align=”center” _builder_version=”4.20.2″ _module_preset=”a348f9e0-d57b-4c22-b522-c52b784fe57f” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_text_color=”#FFFFFF” link_text_color=”#FFFFFF” global_colors_info=”{}”]<\/p>\n

Za op\u0107a pitanja o projektu:<\/p>\n

Marcel Langone Marques<\/strong>
Voditelj projekta<\/p>\n

Sveu\u010dili\u0161te Erasmus u Rotterdamu
marcel.langonemarques@eur.nl<\/a>
Telefon: +31 10 4081583<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.20.2″ _module_preset=”be0fba28-f74a-4ba0-9a8d-9cd30aca805d” background_color=”#048EA3″ global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/06\/My-project-1-7.png” title_text=”Moj projekt-1 (7)” _builder_version=”4.21.0″ _module_preset=”a348f9e0-d57b-4c22-b522-c52b784fe57f” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_text_color=”#FFFFFF” link_text_color=”#FFFFFF” global_colors_info=”{}”]<\/p>\n

Za komunikacije:<\/p>\n

Lena Jessen<\/strong>
Voditelj projekta<\/p>\n

OptiMedis
l.jessen@optimedis.de<\/a>
Telefon: +49 40 226211490<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”partnerlogos” module_id=”utvrditi-vijesti” _builder_version=”4.20.2″ _module_preset=”default” background_color=”#FFFFFF” custom_padding=”0px||0px||true|false” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.0″ _module_preset=”default” positioning=”absolute” position_origin_a=”top_center” custom_padding=”0px|30px|0px|30px|true|true” locked=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_font=”|600|||||||” text_font_size=”36px” header_font=”|600|||||||” header_text_align=”left” header_text_color=”#FFFFFF” header_font_size=”36px” header_line_height=”75px” background_color=”#048EA3″ background_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg” background_size=”custom” background_image_width=”31px” background_image_height=”30px” background_position=”center_right” background_horizontal_offset=”27px” width=”340px” width_tablet=”340px” width_phone=”250px” width_last_edited=”on|phone” height=”75px” height_tablet=”75px” height_phone=”50px” height_last_edited=”on|phone” custom_padding=”|86px|||false|false” link_option_url=”https:\/\/www.access2meds.eu\/hr\/konzorcij\/” header_font_size_tablet=”36px” header_font_size_phone=”24px” header_line_height_tablet=”75px” header_line_height_phone=”50px” header_line_height_last_edited=”on|phone” custom_css_main_element=”overflow:visible;” custom_css_after=”content:%22%22; display:block; width:2000px; height:100%; background:#048ea3; position:absolute; top:0;right:100%;” border_radii=”off||9999px|9999px|” global_colors_info=”{}”]<\/p>\n

Partner<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.2″ _module_preset=”default” module_alignment=”center” custom_padding=”90px|30px|0px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_dp_oc_custom show_arrow=”off” show_control=”off” thumbnail_size=”medium_large” number_thumb=”4″ number_thumb_tablet=”4″ number_thumb_phone=”2″ number_thumb_last_edited=”on|phone” item_margin=”20″ _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”30px||135px||false|false” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Chino.io-logo-1.png” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-chino-srl\/” admin_title=”CINO.IO” _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/EUR-endorsement_01_RGB_2400_colour.png” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-erasmus-universiteit-rotterdam\/” admin_title=”EUR” _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/MPE-Logo-1.png” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-myeloma-patients-europe-aisbl\/” admin_title=”MP” _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Comenius_University_Bratislava-1.svg” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-comenius-university-bratislava\/” admin_title=”CUB” _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/R.png” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-universitetet-i-oslo\/” admin_title=”UiO” _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/06\/wortbildmarke-goeg-RGB.png” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-gesundheit-osterreich-gmbh\/” admin_title=”G\u00d6” _builder_version=”4.25.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/08\/Logo-EHA-Black.png” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-european-hematology-association\/” admin_title=”EHA” _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/AIM-LOGO_png24-1.png” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-association-internationale-de-la-mutualite-aim\/” admin_title=”AIM” _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/OptiMedis_RGB.svg” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-optimedis-ag\/” admin_title=”optimedis” _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][\/et_pb_dp_oc_custom][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

ASCERTAIN bavi se potrebom pacijenata, lije\u010dnika, platitelja, regulatora i proizvo\u0111a\u010da za pobolj\u0161anje priu\u0161tivosti i dostupnosti inovativniim zdravstvenim tehnologijama (uklju\u010duju\u0107i lijekove) u Europi.<\/p>\n","protected":false},"author":1,"featured_media":2542,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-3644","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nASCERTAIN \u2013 POBOLJ\u0160ANJE PRISTUPA INOVATIVNIM ZDRAVSTVENIM TEHNOLOGIJAMA<\/title>\n<meta name=\"description\" content=\"ASCERTAIN bavi se potrebom pacijenata, lije\u010dnika, platitelja, regulatora i proizvo\u0111a\u010da za pobolj\u0161anje priu\u0161tivosti i dostupnosti inovativniim zdravstvenim tehnologijama (uklju\u010duju\u0107i lijekove) u Europi.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.access2meds.eu\/hr\/pocetna-stranica\/\" \/>\n<meta property=\"og:locale\" content=\"hr_HR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ASCERTAIN \u2013 POBOLJ\u0160ANJE PRISTUPADOSTUPNOSTI INOVATIVNE INOVATIVNIM ZDRAVSTVENEIM TEHNOLOGIJEAMA\" \/>\n<meta property=\"og:description\" content=\"ASCERTAIN bavi se potrebom pacijenata, lije\u010dnika, platitelja, regulatora i proizvo\u0111a\u010da za pobolj\u0161anje priu\u0161tivosti i dostupnosti inovativniim zdravstvenim tehnologijama (uklju\u010duju\u0107i lijekove) u Europi.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.access2meds.eu\/hr\/pocetna-stranica\/\" \/>\n<meta property=\"og:site_name\" content=\"ASCERTAIN\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-24T09:02:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"ASCERTAIN \u2013 POBOLJ\u0160ANJE PRISTUPADOSTUPNOSTI INOVATIVNE INOVATIVNIM ZDRAVSTVENEIM TEHNOLOGIJEAMA\" \/>\n<meta name=\"twitter:description\" content=\"ASCERTAIN bavi se potrebom pacijenata, lije\u010dnika, platitelja, regulatora i proizvo\u0111a\u010da za pobolj\u0161anje priu\u0161tivosti i dostupnosti inovativniim zdravstvenim tehnologijama (uklju\u010duju\u0107i lijekove) u Europi.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png\" \/>\n<meta name=\"twitter:site\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:label1\" content=\"Procijenjeno vrijeme \u010ditanja\" \/>\n\t<meta name=\"twitter:data1\" content=\"25 minuta\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/hr\\\/pocetna-stranica\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/hr\\\/pocetna-stranica\\\/\",\"name\":\"ASCERTAIN \u2013 POBOLJ\u0160ANJE PRISTUPA INOVATIVNIM ZDRAVSTVENIM TEHNOLOGIJAMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/hr\\\/pocetna-stranica\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/hr\\\/pocetna-stranica\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/iStock-1217229190_Nastasic.jpg\",\"datePublished\":\"2023-02-27T14:19:01+00:00\",\"dateModified\":\"2025-06-24T09:02:48+00:00\",\"description\":\"ASCERTAIN bavi se potrebom pacijenata, lije\u010dnika, platitelja, regulatora i proizvo\u0111a\u010da za pobolj\u0161anje priu\u0161tivosti i dostupnosti inovativniim zdravstvenim tehnologijama (uklju\u010duju\u0107i lijekove) u Europi.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/hr\\\/pocetna-stranica\\\/#breadcrumb\"},\"inLanguage\":\"hr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.access2meds.eu\\\/hr\\\/pocetna-stranica\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/hr\\\/pocetna-stranica\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/iStock-1217229190_Nastasic.jpg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/iStock-1217229190_Nastasic.jpg\",\"width\":1900,\"height\":1267},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/hr\\\/pocetna-stranica\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.access2meds.eu\\\/hr\\\/pocetna-stranica\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Naslovna stranica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"name\":\"ASCERTAIN\",\"description\":\"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.access2meds.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"hr\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\",\"name\":\"ASCERTAIN\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ASCERTAIN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/ASCERTAIN_EU\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ascertain-eu\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@ascertainproject\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ASCERTAIN \u2013 POBOLJ\u0160ANJE PRISTUPA INOVATIVNIM ZDRAVSTVENIM TEHNOLOGIJAMA","description":"ASCERTAIN bavi se potrebom pacijenata, lije\u010dnika, platitelja, regulatora i proizvo\u0111a\u010da za pobolj\u0161anje priu\u0161tivosti i dostupnosti inovativniim zdravstvenim tehnologijama (uklju\u010duju\u0107i lijekove) u Europi.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.access2meds.eu\/hr\/pocetna-stranica\/","og_locale":"hr_HR","og_type":"article","og_title":"ASCERTAIN \u2013 POBOLJ\u0160ANJE PRISTUPADOSTUPNOSTI INOVATIVNE INOVATIVNIM ZDRAVSTVENEIM TEHNOLOGIJEAMA","og_description":"ASCERTAIN bavi se potrebom pacijenata, lije\u010dnika, platitelja, regulatora i proizvo\u0111a\u010da za pobolj\u0161anje priu\u0161tivosti i dostupnosti inovativniim zdravstvenim tehnologijama (uklju\u010duju\u0107i lijekove) u Europi.","og_url":"https:\/\/www.access2meds.eu\/hr\/pocetna-stranica\/","og_site_name":"ASCERTAIN","article_modified_time":"2025-06-24T09:02:48+00:00","og_image":[{"url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"ASCERTAIN \u2013 POBOLJ\u0160ANJE PRISTUPADOSTUPNOSTI INOVATIVNE INOVATIVNIM ZDRAVSTVENEIM TEHNOLOGIJEAMA","twitter_description":"ASCERTAIN bavi se potrebom pacijenata, lije\u010dnika, platitelja, regulatora i proizvo\u0111a\u010da za pobolj\u0161anje priu\u0161tivosti i dostupnosti inovativniim zdravstvenim tehnologijama (uklju\u010duju\u0107i lijekove) u Europi.","twitter_image":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png","twitter_site":"@ASCERTAIN_EU","twitter_misc":{"Procijenjeno vrijeme \u010ditanja":"25 minuta"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.access2meds.eu\/hr\/pocetna-stranica\/","url":"https:\/\/www.access2meds.eu\/hr\/pocetna-stranica\/","name":"ASCERTAIN \u2013 POBOLJ\u0160ANJE PRISTUPA INOVATIVNIM ZDRAVSTVENIM TEHNOLOGIJAMA","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.access2meds.eu\/hr\/pocetna-stranica\/#primaryimage"},"image":{"@id":"https:\/\/www.access2meds.eu\/hr\/pocetna-stranica\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg","datePublished":"2023-02-27T14:19:01+00:00","dateModified":"2025-06-24T09:02:48+00:00","description":"ASCERTAIN bavi se potrebom pacijenata, lije\u010dnika, platitelja, regulatora i proizvo\u0111a\u010da za pobolj\u0161anje priu\u0161tivosti i dostupnosti inovativniim zdravstvenim tehnologijama (uklju\u010duju\u0107i lijekove) u Europi.","breadcrumb":{"@id":"https:\/\/www.access2meds.eu\/hr\/pocetna-stranica\/#breadcrumb"},"inLanguage":"hr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.access2meds.eu\/hr\/pocetna-stranica\/"]}]},{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.access2meds.eu\/hr\/pocetna-stranica\/#primaryimage","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg","width":1900,"height":1267},{"@type":"BreadcrumbList","@id":"https:\/\/www.access2meds.eu\/hr\/pocetna-stranica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.access2meds.eu\/hr\/pocetna-stranica\/"},{"@type":"ListItem","position":2,"name":"Naslovna stranica"}]},{"@type":"WebSite","@id":"https:\/\/www.access2meds.eu\/#website","url":"https:\/\/www.access2meds.eu\/","name":"ASCERTAIN","description":"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES","publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.access2meds.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"hr"},{"@type":"Organization","@id":"https:\/\/www.access2meds.eu\/#organization","name":"ASCERTAIN","url":"https:\/\/www.access2meds.eu\/","logo":{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","width":1,"height":1,"caption":"ASCERTAIN"},"image":{"@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ASCERTAIN_EU","https:\/\/www.linkedin.com\/company\/ascertain-eu\/","https:\/\/www.youtube.com\/@ascertainproject"]}]}},"_links":{"self":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/pages\/3644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/comments?post=3644"}],"version-history":[{"count":20,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/pages\/3644\/revisions"}],"predecessor-version":[{"id":4565,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/pages\/3644\/revisions\/4565"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/media\/2542"}],"wp:attachment":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/media?parent=3644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}